Travis Smith
Coverage of Travis Smith in the Nexus archive.
- SEE IT: 2-year-old steals show at White House as Trump spotlights 'miracle cure' for deaf boy
President Donald Trump highlighted 2-year-old Travis Smith, who regained hearing after a gene therapy treatment by Regeneron. The FDA granted accelerated approval for Regeneron's Otarmeni, a gene therapy administered surgically, which the company will provide free in the U.S. Trump also noted Regeneron's agreement to offer discounted drug prices.
- SEE IT: 2-year-old steals show at White House as Trump spotlights 'miracle cure' for deaf boy
President Donald Trump highlighted 2-year-old Travis Smith, who regained hearing through Regeneron's Otarmeni gene therapy, during a White House event. The FDA has granted accelerated approval for the treatment, which Regeneron will provide free in the U.S., though administration costs may apply. The therapy involves surgery similar to cochlear implantation.